But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

Key Takeaways Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck ...

By Blake Brittain WASHINGTON - Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic ...

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...

Outlook Therapeutics, Inc. (NASDAQ:OTLK) completed the analysis of the complete 12-week safety and efficacy results for NORSE ...